American Shared Hospital Services
AMSAmerican Shared Hospital Services in brief
American Shared Hospital Services is a listed company in the Medical Care Facilities industry, based in San Francisco, California, USA. Its market value was $10 M on 1 August 2026, which makes it the 25,854th largest listed company in the world and the 4,299th largest in the USA on this site. In the year to December 2025 it had sales of $28 M and a net loss of $2 M. It employs about 44 people. Its largest product and service lines by sales in 2025 were Patient Income (55%), Medical Equipment Leasing (45%) and Rental Income from Medical Services (45%). Its shares trade under the symbol AMS (NYSE).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About American Shared Hospital Services
American Shared Hospital Services is a leading provider of turn-key technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. The main drivers of the Company’s revenue are numbers of sites, procedure volume, and reimbursement. The Company delivers radiation therapy through medical equipment leasing and direct patient services, its two reportable segments. The medical equipment leasing segment, which we also refer to as the Company’s leasing segment, operates by fee-per-use contracts or revenue sharing contracts where the Company shares in the revenue and operating costs of the equipment. The Company’s facilities in Rhode Island, Peru, Ecuador, and Mexico are considered direct patient services, where a contract exists between the Company’s facilities and the individual treated at the facility.
From the company's annual report filed with the US SEC: read the report
American Shared Hospital Services timeline
- 1988
- 🔔· approximateInitial public offering on NYSE
- 1995
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2024
- 💰Record revenue of $28 millionFY2024, the highest of the 8 years on record.
- 💰Record net income of $2 millionFY2024, the highest profit of the 6 years on record.
Events of American Shared Hospital Services from the company record, SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #4,559 (Jan 2020) · #4,518 (Jan 2021) · #5,561 (Jan 2022) · #5,354 (Dec 2022) · #4,412 (Jan 2024) · #2,345 (Mar 2026) · #4,048 (Aug 2026)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- 0.3×
- Price / book
- 0.4×
- Free cash flow yield
- -45.3%
- Net margin (TTM)
- -5.8%
- Operating margin
- -12.8%
- Return on equity
- -7.4%
- Liabilities / assets
- 50.1%
- Net debt
- $14M
- Revenue growth
- -0.9%
- Revenue per employee
- $638 K
- Profit per employee
- $-35 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $28M | -0.9% | $-4M | $-2M | -5.5% |
| Dec 2024 | $28M | +32.9% | $-3M | $2M | 7.7% |
| Dec 2023 | $21M | +7.9% | $0M | $1M | 2.9% |
| Dec 2022 | $20M | +12.0% | $2M | $1M | 6.7% |
| Dec 2021 | $18M | -1.2% | $1M | $0M | 1.1% |
| Dec 2020 | $18M | -13.4% | $-9M | $-7M | -39.6% |
| Dec 2019 | $21M | +4.5% | $2M | $1M | 3.2% |
| Dec 2018 | $20M | — | $2M | $1M | 5.2% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $3M | $8M | $-5M | $-0.23 | — |
| Dec 2024 | $0M | $8M | $-8M | $0.33 | — |
| Dec 2023 | $6M | $6M | $-1M | $0.10 | — |
| Dec 2022 | $7M | $0M | $7M | $0.21 | — |
| Dec 2021 | $6M | $2M | $5M | $0.03 | — |
| Dec 2020 | $10M | $0M | $9M | $-1.14 | — |
| Dec 2019 | $8M | $1M | $7M | $0.11 | — |
| Dec 2018 | $8M | $2M | $6M | $0.17 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $8M (+6.3% on a year earlier), net income $-1M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.
SEC filings
- Nov 12, 20268-KCurrent reportResults of operations
- Aug 13, 202610-QQuarterly report · period to Jun 2026
- Aug 13, 20268-KCurrent reportResults of operations
- Jul 28, 20268-KCurrent reportMaterial agreement · New financial obligation · Unregistered share sale
- Jul 13, 20268-KCurrent reportDirectors or officers changed
- Jun 30, 20268-KCurrent reportDirectors or officers changed · Shareholder vote
- Jun 4, 20268-KCurrent report
- May 14, 202610-QQuarterly report · period to Mar 2026
- May 14, 20268-KCurrent reportResults of operations
- Apr 30, 2026DEF 14AProxy statement
- Apr 24, 20268-KCurrent reportDirectors or officers changed
- Mar 31, 202610-KAnnual report · period to Dec 2025
Official filings of American Shared Hospital Services with the US Securities and Exchange Commission.
Annual results
- Revenue
- $28 M
- Operating income
- $-4 M
- Net income
- $-2 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $55 M
- Total liabilities
- $28 M
- Total equity
- $24 M
As of December-2025
Top 21 institutional investors in American Shared Hospital Services#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | Corient Private Wealth LP | 160,559 | New | 2.41% | $0 M | Nov 16, 2026 |
| 2 | Dimensional Fund Advisors LP | 102,004 | -136 (-0.13%) | 1.53% | $0 M | Nov 4, 2026 |
| 3 | LPL Financial LLC | 81,386 | 0 (0.00%) | 1.22% | $0 M | Nov 6, 2026 |
| 4 | Stifel Financial Corp | 71,250 | New | 1.07% | $0 M | Nov 12, 2026 |
| 5 | Renaissance Technologies LLC | 65,100 | +7,405 (+12.83%) | 0.98% | $0 M | Nov 12, 2026 |
| 6 | Vanguard Capital Management LLC | 55,662 | 0 (0.00%) | 0.84% | $0 M | Nov 13, 2026 |
| 7 | James Investment Research, Inc. | 29,725 | 0 (0.00%) | 0.45% | $0 M | Oct 22, 2026 |
| 8 | NewEdge Advisors, LLC | 29,725 | 0 (0.00%) | 0.45% | $0 M | Nov 13, 2026 |
| 9 | Bridgeway Capital Management, LLC | 28,986 | -138 (-0.47%) | 0.44% | $0 M | Nov 16, 2026 |
| 10 | Geode Capital Management, LLC | 26,036 | -461 (-1.74%) | 0.39% | $0 M | Nov 6, 2026 |
| 11 | Vanguard Fiduciary Trust Co | 25,363 | 0 (0.00%) | 0.38% | $0 M | Nov 13, 2026 |
| 12 | Empowered Funds, LLC | 20,486 | +8,562 (+71.80%) | 0.31% | $0 M | Nov 13, 2026 |
| 13 | XTX Topco Ltd | 20,289 | +1,182 (+6.19%) | 0.31% | $0 M | Nov 16, 2026 |
| 14 | Susquehanna International Group, LLP | 16,223 | New | 0.24% | $0 M | Nov 16, 2026 |
| 15 | UBS Group AG | 13,126 | -5,269 (-28.64%) | 0.20% | $0 M | Nov 10, 2026 |
| 16 | State Street Corp | 12,101 | 0 (0.00%) | 0.18% | $0 M | Nov 12, 2026 |
| 17 | Morgan Stanley | 5,858 | 0 (0.00%) | 0.09% | $0 M | Nov 13, 2026 |
| 18 | Royal Bank Of Canada | 207 | +138 (+200.00%) | 0.00% | $0 M | Nov 16, 2026 |
| 19 | Caitong International Asset Management Co., Ltd | 107 | 0 (0.00%) | 0.00% | $0 M | Oct 29, 2026 |
| 20 | Jones Financial Companies Lllp | 100 | 0 (0.00%) | 0.00% | $0 M | Nov 13, 2026 |
| 21 | Barclays PLC | 3 | -79 (-96.34%) | 0.00% | $0 M | Nov 6, 2026 |
Mutual funds holding American Shared Hospital Services#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 U.S. Small Cap Value PortfolioDimensional Fund Advisors LP | 92,075 | $0 M | 1.4% | <0.01% | −22% | Jul 31, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 55,662 | $0 M | 0.84% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 21,062 | $0 M | 0.32% | <0.01% | −0.8% | May 31, 2026 |
| 🇺🇸 EA Bridgeway Omni Small-Cap Value ETFEmpowered Funds, LLC d/b/a EA Advisers | 11,924 | $0 M | 0.18% | 0% | no change | Jun 30, 2026 |
| 🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC | 8,700 | $0 M | 0.13% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Omni Small-Cap Value FundBridgeway Capital Management, LLC | 8,500 | $0 M | 0.13% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 4,318 | $0 M | 0.06% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Dimensional US Sustainability Core 1 ETFDimensional Fund Advisors LP | 136 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 8 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at American Shared Hospital Services#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Raymond C. StachowiakExecutive Chairman, Director, 10% owner | Buyindirect | +586,468 | $2.280 | $1.3 M | 586,468 | Form 4 |
| filed | Raymond C. StachowiakExecutive Chairman, Director, 10% owner | Grant or award | +100,000 | — | — | 774,678 | Form 4 |
| filed | Raymond C. StachowiakExecutive Chairman, Director, 10% owner | Grant or award | +110,000 | — | — | 664,678 | Form 4 |
| filed | Craig Kenji TagawaPresident | Grant or award | +5,613 | — | — | 35,501 | Form 4 |
| filed | Raymond Scott FrechChief Financial Officer | Grant or award | +50,000 | — | — | 50,000 | Form 4 |
| filed | Gary DelanoisChief Operating Officer | Grant or award | +120,000 | — | — | 120,000 | Form 4 |
| filed | Raymond C. StachowiakExecutive Chairman, Director, 10% owner | Grant or award | +120,000 | — | — | 554,678 | Form 4 |
| filed | Raymond C. StachowiakExecutive Chairman, Director, 10% owner | Grant or award | +120,000 | — | — | 536,178 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: American Shared Hospital Services#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
| Buybacks, quarter | Fiscal | Spent |
|---|---|---|
| Q4 2015 | Q4 2015 | $0M |
| Q3 2015 | Q3 2015 | $0M |
| Q2 2015 | Q2 2015 | $0M |
| Q1 2015 | Q1 2015 | $0M |
| Q4 2014 | Q4 2014 | $0M |
| Q3 2014 | Q3 2014 | $0M |
| Q2 2014 | Q2 2014 | $0M |
| Q1 2014 | Q1 2014 | $0M |
| Q4 2013 | Q4 2013 | $0M |
| Q3 2013 | Q3 2013 | $0M |
| Q1 2013 | Q1 2014 | $0.3M |
| Q3 2012 | Q3 2012 | $0M |
| Q4 2011 | Q4 2011 | $0M |
| Q3 2011 | Q3 2012 | $0M |
Fails to deliver
- : 1 shares at $1.47
- : 21 shares at $1.45
- : 11 shares at $1.39
- : 3 shares at $1.48
- : 8 shares at $1.58
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
American Shared Hospital Services scorecard#
Passes 6 of the 18 checks that could be worked out: strongest in growth (3 of 6), weakest in profitability (0 of 5). Fiscal year 2025; market cap of Aug 1, 2026.
Valuationnot known
- –P/E below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to book below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to sales below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Free cash flow yield above 5%The market cap dates from 2026-08-01, more than 60 days ago.
- –Earnings yield above the 10-year Treasury yieldThe market cap dates from 2026-08-01, more than 60 days ago.
- –The price assumes slower growth than the last three years'The market cap dates from 2026-08-01, more than 60 days ago.
Growth3 of 6
- ✗Revenue grew in the newest year-0.9%Revenue down 0.9% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years12.4%12.4% a year over the three years to fiscal 2025.
- ✓Faster growth over three years than its peers' median12.4%12.4% a year against Medical Care Facilities's median of 9.0% (33 companies).
- ✗Earnings per share grew in the newest year-0.23 vs 0.33Diluted EPS -0.23 in fiscal 2025 against 0.33 the year before (report's currency).
- ✓Net income higher than five years earlier-$2 M-$2 M in fiscal 2025 against -$7 M in 2020.
- ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2025.
Profitability0 of 5
- ✗Profitable in the newest year-$2 MNet income -$2 M in fiscal 2025.
- ✗Profitable in each of the last five years4 of 5Profitable in 4 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-12.8%-12.8% against Medical Care Facilities's median of 7.9% (36 companies).
- ✗Return on equity above 15%-6.3%-6.3% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✗Operating margin wider than three years earlier-12.8%-12.8% in fiscal 2025 against 12.3% in 2022.
Financial health2 of 6
- ✗Short-term assets cover short-term liabilities0.8×Current ratio 0.76 at the end of fiscal 2025.
- ✓Debt below equity0.7×Debt to equity 0.72 at the end of fiscal 2025.
- ✗Net debt below three years of EBITDA6.6×Net debt 6.6 times EBITDA in fiscal 2025.
- ✗Operating income covers interest five times-2.3×Operating income -2.3 times interest in fiscal 2025.
- ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone0.49Z-score 0.49 (distress zone) for fiscal 2025.
Shareholder returns1 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✓Share count up no more than 2% in a year-1.3%Diluted shares down 1.3% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueThe market cap dates from 2026-08-01, more than 60 days ago.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Medical Care Facilities, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from American Shared Hospital Services's statements, beside the median of Medical Care Facilities.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | -12.8% | 7.9% | |
| Net margin | -5.5% | 3.2% | |
| Return on equity | -6.3% | 8.2% | |
| Revenue growth, 3 years a year | 12.5% | 9.0% | |
| Revenue growth | -0.9% | 6.7% | |
| Debt to equity | 0.72× | 0.56× |
4of 9on the Piotroski tests of financial strength
- Revenue fell 0.9% against the year before.
- Net loss of $2 million.
- Free cash flow was negative: -$5 million.
- Net debt is 6.6 times a year's operating earnings before depreciation.
American Shared Hospital Services: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 | FY 2018to Dec 31, 2018 | FY 2017to Dec 31, 2017 | FY 2016to Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 28,082−0.9%100% | 28,340+32.9%100% | 21,325+8.0%100% | 19,746+12.0%100% | 17,628−1.2%100% | 17,837−13.4%100% | 20,605+4.5%100% | 19,714+0.8%100% | 19,556+4.6%100% | 18,700—100% | |
| Cost of revenue | 23,018+20.2%82.0% | 19,155+59.9%67.6% | 11,981+5.4%56.2% | 11,364+4.2%57.6% | 10,902−18.5%61.8% | 13,371—75.0% | — | 12,228+12.3%62.0% | 10,893+10.0%55.7% | 9,905—53.0% | |
| Gross profit | 5,064−44.9%18.0% | 9,185−1.7%32.4% | 9,344+11.5%43.8% | 8,382+24.6%42.4% | 6,726+50.6%38.2% | 4,466−35.5%25.0% | 6,920−7.6%33.6% | 7,486−13.6%38.0% | 8,663−1.5%44.3% | 8,795—47.0% | |
| Selling, general and administrative | 7,078−4.4%25.2% | 7,407+5.5%26.1% | 7,022+36.5%32.9% | 5,145+13.6%26.1% | 4,531−1.7%25.7% | 4,608+13.5%25.8% | 4,060+1.7%19.7% | 3,994−7.6%20.3% | 4,323+13.7%22.1% | 3,802—20.3% | |
| Total costs and expenses | — | — | — | — | — | 13,371−2.3%75.0% | 13,685+11.9%66.4% | 12,228+12.3%62.0% | 10,893—55.7% | — | |
| Operating income | −3,588—−12.8% | −2,805−1139%−9.9% | 270−88.9%1.3% | 2,431+79.9%12.3% | 1,351—7.7% | −9,463−714%−53.1% | 1,542−17.1%7.5% | 1,861−22.9%9.4% | 2,413−26.6%12.3% | 3,286—17.6% | |
| Interest expense and finance costs | 1,574+5.0%5.6% | 1,499+34.8%5.3% | 1,112+38.0%5.2% | 806+9.1%4.1% | 739−30.1%4.2% | 1,057−19.8%5.9% | 1,318−19.2%6.4% | 1,631−15.4%8.3% | 1,927+12.9%9.9% | 1,707—9.1% | |
| Income before tax | −3,220−360%−11.5% | 1,237+77.7%4.4% | 696−72.4%3.3% | 2,518+166%12.8% | 947—5.4% | −9,453−707%−53.0% | 1,558−25.1%7.6% | 2,081+13.3%10.6% | 1,837−42.5%9.4% | 3,193—17.1% | |
| Income tax | −493—−1.8% | −295−168%−1.0% | 431−55.2%2.0% | 963+258%4.9% | 269—1.5% | −1,737−1457%−9.7% | 128−71.6%0.6% | 451—2.3% | −1,103−217%−5.6% | 943—5.0% | |
| Net income including minority interests | −2,727−278%−9.7% | 1,532+478%5.4% | 265−83.0%1.2% | 1,555+129%7.9% | 678—3.8% | −7,716−640%−43.3% | 1,430−12.3%6.9% | 1,630−44.6%8.3% | 2,940+30.7%15.0% | 2,250—12.0% | |
| Minority interests' share of net income | −1,174—−4.2% | −654—−2.3% | −345−252%−1.6% | 227−53.1%1.1% | 484—2.7% | −658−185%−3.7% | 771+27.0%3.7% | 607−40.3%3.1% | 1,017−23.0%5.2% | 1,320—7.1% | |
| Net income attributable to shareholders | −1,553−171%−5.5% | 2,186+258%7.7% | 610−54.1%2.9% | 1,328+585%6.7% | 194—1.1% | −7,058−1171%−39.6% | 659−35.6%3.2% | 1,023−46.8%5.2% | 1,923+107%9.8% | 930—5.0% | |
| Earnings per share, basic | -0.23−168%— | 0.34+240%— | 0.10−52.4%— | 0.21+600%— | 0.03—— | -1.14−1136%— | 0.11−38.9%— | 0.18−45.5%— | 0.33+94.1%— | 0.17—— | |
| Earnings per share, diluted | -0.23−170%— | 0.33+230%— | 0.10−52.4%— | 0.21+600%— | 0.03—— | -1.14−1136%— | 0.11−35.3%— | 0.17−48.5%— | 0.33+94.1%— | 0.17—— | |
| Shares, weighted average (basic) | 6.6+1.8%— | 6.5+2.2%— | 6.4+1.0%— | 6.3+4.2%— | 6.0−2.2%— | 6.2—— | — | — | — | — | |
| Shares, weighted average (diluted) | 6.6−1.3%— | 6.7+4.8%— | 6.4+1.4%— | 6.3+4.0%— | 6.1−2.0%— | 6.2+4.2%— | 5.9+1.3%— | 5.9−0.5%— | 5.9+5.4%— | 5.6—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 3,462−68.6%6.2% | 11,025−19.5%18.3% | 13,690+11.0%28.4% | 12,335+51.4%28.1% | 8,145+106%17.9% | 3,961+177%9.1% | 1,429−0.9%2.7% | 1,442−33.0%2.5% | 2,152−25.0%3.7% | 2,871—4.7% | |
| Receivables | 10,521−9.4%19.0% | 11,610+167%19.3% | 4,343+14.3%9.0% | 3,801−9.7%8.6% | 4,211−2.1%9.3% | 4,303−37.6%9.9% | 6,894+25.3%12.8% | 5,502+9.6%9.6% | 5,019+22.9%8.6% | 4,085—6.7% | |
| Other current assets | 786r774−15.3%1.4% | 928+76.4%1.5% | 526−41.4%1.1% | 897+8.6%2.0% | 826+5.8%1.8% | 781r1,950−58.9%1.8% | 1,900+48.9%3.5% | 1,276+10.4%2.2% | 1,156+212%2.0% | 370r892—0.6% | |
| Current assets | 17,720−32.5%31.9% | 26,258+28.4%43.6% | 20,456+9.3%42.5% | 18,723+24.1%42.6% | 15,087+39.1%33.2% | 10,850+1.0%24.9% | 10,742+8.0%20.0% | 9,946+11.8%17.3% | 8,893+13.1%15.3% | 7,866r8,388—13.0% | |
| Property, plant and equipment | — | 72,854−10.3%121% | 81,227+9.4%169% | 74,237—169% | — | 30,418−26.7%69.7% | 41,480−11.2%77.1% | 46,694−3.7%81.2% | 48,491−5.5%83.4% | 51,331—84.7% | |
| Right-of-use (leased) assets | 3,648+259%6.6% | 1,015+1681%1.7% | 57−82.0%0.1% | 317−51.5%0.7% | 654−26.2%1.4% | 886−19.9%2.0% | 1,106—2.1% | 0—0.0% | — | — | |
| Goodwill | 1,2650.0%2.3% | 1,2650.0%2.1% | 1,2650.0%2.6% | 1,2650.0%2.9% | 1,2650.0%2.8% | 1,265—2.9% | 0—0.0% | — | — | — | |
| Other intangible assets | 780.0%0.1% | 780.0%0.1% | 780.0%0.2% | 780.0%0.2% | 780.0%0.2% | 78—0.2% | 0—0.0% | — | — | — | |
| Investments in associates | — | — | — | — | — | — | — | — | 0−100%0.0% | 579—1.0% | |
| Total assets | 55,479−7.8%100% | 60,197+25.0%100% | 48,162+9.6%100% | 43,956−3.2%100% | 45,430+4.1%100% | 43,653−18.8%100% | 53,783−6.5%100% | 57,502−1.2%100% | 58,176−4.0%100% | 60,598—100% | |
| Accounts payable | 607−61.1%1.1% | 1,562+396%2.6% | 315+37.0%0.7% | 230−27.7%0.5% | 318r746−53.4%0.7% | 683+22.6%1.6% | 557+28.0%1.0% | 435+21.2%0.8% | 359+12.5%0.6% | 319—0.5% | |
| Debt due within a year | 17,294+509%31.2% | 2,841+36.3%4.7% | 2,084+65.1%4.3% | 1,262+16.7%2.9% | 1,081−6.6%2.4% | 1,157−24.2%2.7% | 1,526−28.0%2.8% | 2,119−13.8%3.7% | 2,459+11.5%4.2% | 2,205—3.6% | |
| Current liabilities | 23,444+125%42.3% | 10,405−3.5%17.3% | 10,779+108%22.4% | 5,175−12.2%11.8% | 5,891−52.4%13.0% | 12,380+50.7%28.4% | 8,214−13.3%15.3% | 9,474+5.2%16.5% | 9,007+3.8%15.5% | 8,681—14.3% | |
| Long-term debt | 0−100%0.0% | 17,341+57.1%28.8% | 11,041−9.5%22.9% | 12,205−14.8%27.8% | 14,323+316%31.5% | 3,440+76.0%7.9% | 1,954−41.4%3.6% | 3,332−7.4%5.8% | 3,598−29.5%6.2% | 5,106—8.4% | |
| Lease liabilities (non-current) | 4,229+182%7.6% | 1,500—2.5% | 0−100%0.0% | 59−83.6%0.1% | 359−38.2%0.8% | 581−29.7%1.3% | 827—1.5% | 0—0.0% | — | — | |
| Total liabilities | 27,788−7.9%50.1% | 30,170+37.9%50.1% | 21,883+19.4%45.4% | 18,331−13.5%41.7% | 21,191—46.6% | — | — | — | — | — | |
| Retained earnings | 4,262−26.7%7.7% | 5,815+60.2%9.7% | 3,629+20.2%7.5% | 3,019+78.5%6.9% | 1,691+13.0%3.7% | 1,497−82.5%3.4% | 8,555+8.3%15.9% | 7,896+14.9%13.7% | 6,873+38.8%11.8% | 4,950—8.2% | |
| Shareholders' equity | 24,034−4.6%43.3% | 25,183+11.3%41.8% | 22,624+4.6%47.0% | 21,625+8.7%49.2% | 19,893+3.2%43.8% | 19,274−26.0%44.2% | 26,033+3.7%48.4% | 25,102+5.2%43.7% | 23,856+11.0%41.0% | 21,495—35.5% | |
| Minority interests | 3,657−24.5%6.6% | 4,844+32.5%8.0% | 3,655−8.6%7.6% | 4,000−8.0%9.1% | 4,346−0.7%9.6% | 4,376−24.3%10.0% | 5,778−2.8%10.7% | 5,946−1.4%10.3% | 6,029+6.2%10.4% | 5,678—9.4% | |
| Total equity | 27,691−7.8%49.9% | 30,027+14.3%49.9% | 26,279+2.6%54.6% | 25,625+5.7%58.3% | 24,239+2.5%53.4% | 23,650−25.7%54.2% | 31,811+2.5%59.1% | 31,048+3.9%54.0% | 29,885+10.0%51.4% | 27,173—44.8% | |
| Total liabilities and equity | 55,479−7.8%100% | 60,197+25.0%100% | 48,162+9.6%100% | 43,956−3.2%100% | 45,430+4.1%100% | 43,653−18.8%100% | 53,783−6.5%100% | 57,502−1.2%100% | 58,176−4.0%100% | 60,598—100% | |
| Shares outstanding | 6.6+2.4%— | 6.4+1.9%— | 6.3+1.9%— | 6.2+2.2%— | 6.0+4.5%— | 5.8−0.4%— | 5.8+1.8%— | 5.7+0.1%— | 5.7+4.4%— | 5.5—— | |
| Cash-flow statement | |||||||||||
| Depreciation and amortization | 5,714−7.5%20.3% | 6,174+19.5%21.8% | 5,165+8.0%24.2% | 4,783−3.8%24.2% | 4,972−28.7%28.2% | 6,970−6.0%39.1% | 7,411+8.7%36.0% | 6,818+2.1%34.6% | 6,677+5.5%34.1% | 6,327—33.8% | |
| Share-based compensation | 404+8.3%1.4% | 373−4.1%1.3% | 389−2.5%1.8% | 399−5.0%2.0% | 420+40.5%2.4% | 299+30.0%1.7% | 230+3.1%1.1% | 223−31.0%1.1% | 323+50.2%1.7% | 215—1.1% | |
| Cash from operating activities | 3,098+1755%11.0% | 167−97.1%0.6% | 5,718−21.0%26.8% | 7,235+15.4%36.6% | 6,267−35.7%35.6% | 9,745+21.1%54.6% | 8,047−0.2%39.1% | 8,062+2.7%40.9% | 7,853−6.3%40.2% | 8,378—44.8% | |
| Capital expenditure | −7,634—−27.2% | −7,938—−28.0% | −6,273—−29.4% | −388—−2.0% | −1,674—−9.5% | −455—−2.6% | −990—−4.8% | −1,577—−8.0% | −803—−4.1% | −1,042r−1,612—−5.6% | |
| Acquisitions, net of cash acquired | 0—0.0% | −538—−1.9% | 0—0.0% | — | 0—0.0% | −2,084—−11.7% | 0—0.0% | — | — | — | |
| Cash from investing activities | −7,634—−27.2% | −7,105—−25.1% | −6,273—−29.4% | −388—−2.0% | −1,674—−9.5% | −2,389—−13.4% | −990—−4.8% | −1,526—−7.7% | −653—−3.3% | −1,042r−1,612—−5.6% | |
| Debt issued | 0−100%0.0% | 9,860+463%34.8% | 1,750—8.2% | 0−100%0.0% | 13,897—78.8% | 0—0.0% | — | — | — | — | |
| Debt repaid | −3,014—−10.7% | −2,734—−9.6% | −2,129—−10.0% | −2,032—−10.3% | −3,927—−22.3% | −1,726—−9.7% | −1,980—−9.6% | −2,467—−12.5% | −2,314—−11.8% | −2,968—−15.9% | |
| Shares bought back | — | — | — | — | — | — | — | — | — | 0—0.0% | |
| Cash from financing activities | −3,027−169%−10.8% | 4,405+131%15.5% | 1,910—9.0% | −2,657—−13.5% | −655—−3.7% | −4,810—−27.0% | −7,070—−34.3% | −7,246—−36.8% | −7,819r−7,919—−40.0% | −6,474r−6,104—−34.6% | |
| Change in cash | −7,563—−26.9% | −2,533−287%−8.9% | 1,355−67.7%6.4% | 4,190+6.4%21.2% | 3,938+54.7%22.3% | 2,546—14.3% | −13—−0.1% | −710—−3.6% | −619r−719−172%−3.2% | 862r662—4.6% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 30,866+4.9%100% | 7,624+6.3%100% | 8,430+19.2%100% | 7,084+15.9%100% | 7,728*−14.8%100% | 7,171+2.5%100% | 7,071+0.2%100% | 6,112+17.2%100% | 9,069*+59.2%100% | 6,999—100% | 7,056—100% | 5,216—100% | 5,698*—100% | |
| Cost of revenue | 25,720+16.6%83.3% | 6,105+9.3%80.1% | 6,997+28.6%83.0% | 5,796+12.1%81.8% | 6,822*+16.3%88.3% | 5,585−0.8%77.9% | 5,441+18.6%76.9% | 5,170+68.2%84.6% | 5,865*+104%64.7% | 5,629—80.4% | 4,588—65.0% | 3,073—58.9% | 2,882*—50.6% | |
| Gross profit | 5,146−30.1%16.7% | 1,519−4.2%19.9% | 1,433−12.1%17.0% | 1,288+36.7%18.2% | 906*−71.7%11.7% | 1,586+15.8%22.1% | 1,630−34.0%23.1% | 942−56.0%15.4% | 3,204*+13.8%35.3% | 1,370—19.6% | 2,468—35.0% | 2,143—41.1% | 2,816*—49.4% | |
| Selling, general and administrative | 7,741+13.8%25.1% | 1,803+17.2%23.6% | 2,042+17.0%24.2% | 1,910+5.6%27.0% | 1,986*+16.2%25.7% | 1,538−20.0%21.4% | 1,746−7.9%24.7% | 1,808−3.8%29.6% | 1,709*−2.9%18.8% | 1,923—27.5% | 1,896—26.9% | 1,879—36.0% | 1,760*—30.9% | |
| Operating income | −3,999—−13.0% | −764—−10.0% | −910—−10.8% | −924—−13.0% | −1,401*—−18.1% | −344—−4.8% | −544—−7.7% | −1,299—−21.3% | −1,830*−550%−20.2% | −889—−12.7% | −1.0—−0.0% | −85—−1.6% | 407*—7.1% | |
| Interest expense and finance costs | 1,404−16.5%4.5% | 480+22.4%6.3% | 301−29.7%3.6% | 302−30.3%4.3% | 321*−25.2%4.2% | 392+16.7%5.5% | 428+11.2%6.1% | 433+24.1%7.1% | 429*+49.5%4.7% | 336—4.8% | 385—5.5% | 349—6.7% | 287*—5.0% | |
| Income before tax | −3,681—−11.9% | −743—−9.7% | −863—−10.2% | −870—−12.3% | −1,205*—−15.6% | −281—−3.9% | −499−113%−7.1% | −1,235−5981%−20.2% | −1,942*−477%−21.4% | −579—−8.3% | 3,737—53.0% | 21—0.4% | 515*—9.0% | |
| Income tax | 193—0.6% | 163+240%2.1% | 135—1.6% | 92—1.3% | −197*—−2.5% | 48—0.7% | −21—−0.3% | −323—−5.3% | −51*−115%−0.6% | −169—−2.4% | −31—−0.4% | −44—−0.8% | 338*—5.9% | |
| Net income including minority interests | −3,874—−12.6% | −906—−11.9% | −998—−11.8% | −962—−13.6% | −1,008*—−13.0% | −329—−4.6% | −478−113%−6.8% | −912−1503%−14.9% | −1,891*−1168%−20.9% | −410—−5.9% | 3,768—53.4% | 65—1.2% | 177*—3.1% | |
| Minority interests' share of net income | −1,497—−4.8% | −286—−3.8% | −484—−5.7% | −350—−4.9% | −377*—−4.9% | −312—−4.4% | −198−219%−2.8% | −287—−4.7% | −563*—−6.2% | −203—−2.9% | 166—2.4% | −54—−1.0% | −238*—−4.2% | |
| Net income attributable to shareholders | −2,377—−7.7% | −620—−8.1% | −514—−6.1% | −612—−8.6% | −631*—−8.2% | −17—−0.2% | −280−108%−4.0% | −625−625%−10.2% | −1,328*−420%−14.6% | −207—−3.0% | 3,602—51.0% | 119—2.3% | 415*—7.3% | |
| Earnings per share, basic | — | -0.09—— | -0.07—— | -0.09—— | — | 0.00—— | -0.04−107%— | -0.10−600%— | — | -0.03—— | 0.56—— | 0.02—— | — | |
| Earnings per share, diluted | — | -0.09—— | -0.07—— | -0.09—— | — | 0.00—— | -0.04−107%— | -0.10−600%— | — | -0.03—— | 0.55—— | 0.02—— | — | |
| Shares, weighted average (basic) | 6.8+2.1%— | 6.8+2.1%— | 6.9+4.4%— | 6.7+2.3%— | — | 6.6+2.3%— | 6.6+1.5%— | 6.6+1.9%— | — | 6.5—— | 6.5—— | 6.5—— | — | |
| Shares, weighted average (diluted) | 6.8+2.1%— | 6.8+2.1%— | 6.9+4.4%— | 6.7+2.3%— | — | 6.6+2.3%— | 6.6−0.0%— | 6.6−0.1%— | — | 6.5—— | 6.6—— | 6.6—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 7,230—13.7% | 7,230+41.9%13.7% | 6,511−41.2%12.4% | 4,973−55.8%9.1% | 3,462−68.6%6.2% | 5,095−63.2%8.5% | 11,081−22.2%17.5% | 11,241−12.1%17.8% | 11,025−19.5%18.3% | 13,827—21.9% | 14,236—23.4% | 12,792—25.5% | 13,690—28.4% | |
| Receivables | 7,636—14.4% | 7,636−35.3%14.4% | 8,323−13.1%15.9% | 10,566+20.9%19.3% | 10,521−9.4%19.0% | 11,806+36.7%19.8% | 9,576+11.3%15.1% | 8,737+35.9%13.8% | 11,610+167%19.3% | 8,635—13.6% | 8,606—14.1% | 6,429—12.8% | 4,343—9.0% | |
| Other current assets | 641—1.2% | 641+9.4%1.2% | 830+14.5%1.6% | 830+5.7%1.5% | 786r774−15.3%1.4% | 586−22.6%1.0% | 725+16.4%1.1% | 785+51.8%1.2% | 928+76.4%1.5% | 757—1.2% | 623—1.0% | 517—1.0% | 526—1.1% | |
| Current assets | 19,059—36.1% | 19,059−7.4%36.1% | 17,368−28.9%33.1% | 18,272−23.0%33.4% | 17,720−32.5%31.9% | 20,591−19.9%34.5% | 24,433−4.7%38.5% | 23,742+11.1%37.5% | 26,258+28.4%43.6% | 25,720—40.7% | 25,639—42.2% | 21,365—42.6% | 20,456—42.5% | |
| Property, plant and equipment | — | — | — | — | — | — | — | — | 72,854−10.3%121% | 80,692—128% | 81,809—134% | 79,135—158% | 81,227—169% | |
| Right-of-use (leased) assets | 3,531—6.7% | 3,531−5.8%6.7% | 3,571+18.6%6.8% | 3,610+17.8%6.6% | 3,648+259%6.6% | 3,750+280%6.3% | 3,011+377%4.7% | 3,064+8411%4.8% | 1,015+1681%1.7% | 986—1.6% | 631—1.0% | 36—0.1% | 57—0.1% | |
| Goodwill | 1,265—2.4% | 1,2650.0%2.4% | 1,2650.0%2.4% | 1,2650.0%2.3% | 1,2650.0%2.3% | 1,2650.0%2.1% | 1,2650.0%2.0% | 1,2650.0%2.0% | 1,2650.0%2.1% | 1,265—2.0% | 1,265—2.1% | 1,265—2.5% | 1,265—2.6% | |
| Other intangible assets | 78—0.1% | 780.0%0.1% | 780.0%0.1% | 780.0%0.1% | 780.0%0.1% | 780.0%0.1% | 780.0%0.1% | 780.0%0.1% | 780.0%0.1% | 78—0.1% | 78—0.1% | 78—0.2% | 78—0.2% | |
| Total assets | 52,865—100% | 52,865−11.3%100% | 52,493−17.3%100% | 54,725−13.6%100% | 55,479−7.8%100% | 59,629−5.8%100% | 63,494+4.4%100% | 63,311+26.3%100% | 60,197+25.0%100% | 63,269—100% | 60,825—100% | 50,124—100% | 48,162—100% | |
| Accounts payable | 615—1.2% | 615−44.4%1.2% | 582−27.8%1.1% | 1,081−12.2%2.0% | 607−61.1%1.1% | 1,107−38.0%1.9% | 806−6.2%1.3% | 1,231+361%1.9% | 1,562+396%2.6% | 1,786—2.8% | 859—1.4% | 267—0.5% | 315—0.7% | |
| Debt due within a year | — | — | 16,216+64.3%30.9% | 16,843+438%30.8% | 17,294+509%31.2% | 18,184r9,553+411%30.5% | 9,872+225%15.5% | 3,128+15.4%4.9% | 2,841+36.3%4.7% | 3,557—5.6% | 3,033—5.0% | 2,710—5.4% | 2,084—4.3% | |
| Current liabilities | 23,627—44.7% | 23,627−8.4%44.7% | 22,424+7.5%42.7% | 23,718+86.6%43.3% | 23,444+125%42.3% | 25,802r17,171+46.9%43.3% | 20,860+56.4%32.9% | 12,710+17.9%20.1% | 10,405−3.5%17.3% | 17,561—27.8% | 13,336—21.9% | 10,779—21.5% | 10,779—22.4% | |
| Long-term debt | — | — | — | — | 0−100%0.0% | 0r8,631−100%0.0% | 9,222−23.5%14.5% | 16,798+30.3%26.5% | 17,341+57.1%28.8% | 10,818—17.1% | 12,050—19.8% | 12,892—25.7% | 11,041—22.9% | |
| Lease liabilities (non-current) | 4,103—7.8% | 4,103−4.7%7.8% | 4,145+13.9%7.9% | 4,187+14.2%7.7% | 4,229+182%7.6% | 4,304+187%7.2% | 3,640+125%5.7% | 3,667—5.8% | 1,500—2.5% | 1,500—2.4% | 1,615—2.7% | — | 0—0.0% | |
| Total liabilities | 27,845—52.7% | 27,845−10.3%52.7% | 26,684−23.0%50.8% | 28,020−17.8%51.2% | 27,788−7.9%50.1% | 31,030−1.3%52.0% | 34,646+21.7%54.6% | 34,099+43.6%53.9% | 30,170+37.9%50.1% | 31,439—49.7% | 28,473—46.8% | 23,739—47.4% | 21,883—45.4% | |
| Retained earnings | 2,516—4.8% | 2,516−48.6%4.8% | 3,136−36.1%6.0% | 3,650−29.7%6.7% | 4,262−26.7%7.7% | 4,893−31.5%8.2% | 4,910−33.2%7.7% | 5,190+38.5%8.2% | 5,815+60.2%9.7% | 7,143—11.3% | 7,350—12.1% | 3,748—7.5% | 3,629—7.5% | |
| Shareholders' equity | 22,608—42.8% | 22,608−8.0%42.8% | 23,111−5.6%44.0% | 23,523−4.6%43.0% | 24,034−4.6%43.3% | 24,565−7.0%41.2% | 24,481−7.8%38.6% | 24,647+7.9%38.9% | 25,183+11.3%41.8% | 26,423—41.8% | 26,542—43.6% | 22,841—45.6% | 22,624—47.0% | |
| Minority interests | 2,412—4.6% | 2,412−40.2%4.6% | 2,698−38.2%5.1% | 3,182−30.3%5.8% | 3,657−24.5%6.6% | 4,034−25.4%6.8% | 4,367−24.8%6.9% | 4,565+28.8%7.2% | 4,844+32.5%8.0% | 5,407—8.5% | 5,810—9.6% | 3,544—7.1% | 3,655—7.6% | |
| Total equity | 25,020—47.3% | 25,020−12.5%47.3% | 25,809−10.5%49.2% | 26,705−8.6%48.8% | 27,691−7.8%49.9% | 28,599−10.2%48.0% | 28,848−10.8%45.4% | 29,212+10.7%46.1% | 30,027+14.3%49.9% | 31,830—50.3% | 32,352—53.2% | 26,385—52.6% | 26,279—54.6% | |
| Total liabilities and equity | 52,865—100% | 52,865−11.3%100% | 52,493−17.3%100% | 54,725−13.6%100% | 55,479−7.8%100% | 59,629−5.8%100% | 63,494+4.4%100% | 63,311+26.3%100% | 60,197+25.0%100% | 63,269—100% | 60,825—100% | 50,124—100% | 48,162—100% | |
| Shares outstanding | 6.7—— | 6.7+2.2%— | 6.6+2.2%— | 6.6+2.3%— | 6.6+2.4%— | 6.5+1.9%— | 6.5+1.9%— | 6.5+1.9%— | 6.4+1.9%— | 6.4—— | 6.4—— | 6.3—— | 6.3—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 5,285−13.1%17.1% | 1,342−7.7%17.6% | 1,346−10.7%16.0% | 1,294−10.7%18.3% | 1,303*−22.1%16.9% | 1,454−11.6%20.3% | 1,508−1.0%21.3% | 1,449+8.6%23.7% | 1,673*+29.6%18.4% | 1,644—23.5% | 1,523—21.6% | 1,334—25.6% | 1,291*—22.7% | |
| Share-based compensation | 341−13.0%1.1% | 38*−62.4%0.5% | 102*−10.5%1.2% | 101+13.5%1.4% | 100*+13.6%1.3% | 101*+14.8%1.4% | 114*+15.2%1.6% | 89−9.2%1.5% | 88*−10.2%1.0% | 88*—1.3% | 99*—1.4% | 98—1.9% | 98*—1.7% | |
| Cash from operating activities | 5,103+25.2%16.5% | 1,422*−14.9%18.7% | 2,236*—26.5% | 2,149−14.1%30.3% | −704*−357%−9.1% | 1,671*+254%23.3% | −372*−129%−5.3% | 2,503—41.0% | 274*—3.0% | 472*—6.7% | 1,286*—18.2% | −1,865—−35.8% | −3,060*—−53.7% | |
| Capital expenditure | — | −76*—−1.0% | −58*—−0.7% | −41—−0.6% | — | −3,702*—−51.6% | −1,901*—−26.9% | −4,015—−65.7% | −4,660*—−51.4% | −879*—−12.6% | −1,216*—−17.2% | −1,183—−22.7% | −97*—−1.7% | |
| Acquisitions, net of cash acquired | — | — | — | — | 0*—0.0% | 0*—0.0% | — | — | 0*—0.0% | — | — | — | 0*—0.0% | |
| Cash from investing activities | 1,809—5.9% | −76*—−1.0% | −58*—−0.7% | −41—−0.6% | 1,984*—25.7% | −3,702*—−51.6% | −1,901*—−26.9% | −4,015—−65.7% | −4,365*—−48.1% | −704*—−10.1% | −853*—−12.1% | −1,183—−22.7% | −97*—−1.7% | |
| Debt issued | — | — | — | — | 0*−100%0.0% | 0*—0.0% | 0*—0.0% | 0−100%0.0% | 7,160*—79.0% | 0*—0.0% | 0*—0.0% | 2,700—51.8% | — | |
| Debt repaid | −2,587—−8.4% | −562*—−7.4% | −640*—−7.6% | −472—−6.7% | −913*—−11.8% | −934*—−13.0% | −887*—−12.5% | −280—−4.6% | −1,304*—−14.4% | −727*—−10.4% | −539*—−7.6% | −164—−3.1% | −540*—−9.5% | |
| Cash from financing activities | −2,772−336%−9.0% | 1,378*—18.1% | −640*−130%−7.6% | −597−135%−8.4% | −2,913*−326%−37.7% | −3,955*—−55.2% | 2,113*+109%29.9% | 1,728−24.3%28.3% | 1,289*−44.2%14.2% | −177*—−2.5% | 1,011*—14.3% | 2,282—43.8% | 2,310*—40.5% | |
| Change in cash | 4,140—13.4% | 2,724*—35.7% | 1,538*—18.2% | 1,511+600%21.3% | −1,633*—−21.1% | −5,986*—−83.5% | −160*−111%−2.3% | 216—3.5% | −2,802*—−30.9% | −409*—−5.8% | 1,444*—20.5% | −766—−14.7% | −847*—−14.9% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What American Shared Hospital Services sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Products and services
- Patient Income$16 M55%+24%
- Rental Income from Medical Services$13 M45%-20%
- Medical Equipment Leasing$13 M45%-20%
- PBRT Services$7 M26%-26%
Business segments
- Direct Patient Services$16 M55%+24%
- Medical Equipment Leasing$13 M45%-20%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Executive pay at American Shared Hospital Services#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2025Chief executive | $526 K | $523 K | $386 K | $71 |
| 2024Chief executive | $603 K | $667 K | $465 K | $132 |
| 2023Chief executive | $627 K | $589 K | $395 K | $81 |
Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025
Events at American Shared Hospital Services#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Warning signs in the last three years
Financial statements withdrawn 1 · Auditor changed 1 · Debt called early 1 · Acquisition or sale completed 1 · Directors and officers 7 · Material agreement 4 · New debt 2 · Unregistered share sale 1 · Shareholder vote 3 · Results announced 11
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Results announced | 8-K | |
| Material agreementNew debtUnregistered share sale | 8-K | |
| Directors and officers | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Debt called early | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Financial statements withdrawn | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Directors and officers | 8-K/A | |
| Auditor changed | 8-K | |
| Results announced | 8-K | |
| Directors and officersResults announced | 8-K | |
| Directors and officersMaterial agreementNew debt | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Acquisition or sale completedMaterial agreement | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 12, 2026
Acquisitions and funding#
1 acquisitions, $5 M paid where reported
Businesses it acquired
| Acquired | Acquisition date | Completion | Price | Stake | Source |
|---|---|---|---|---|---|
| Southern New England Regional Cancer Center, LLC and Roger Williams Radiation Therapy, LLC | 2024 | — | $5 M | 60% | Annual report |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
How American Shared Hospital Services compares in Medical Care Facilities
- Market cap$10 M · higher than 2% of 113
- Revenue$28 M · higher than 5% of 131
- Net margin-5.8% · higher than 9% of 127
- Revenue growth-0.9% · higher than 17% of 53
- Price / sales0.3× · lower than 94% of 82
- Price / book0.4× · lower than 99% of 71
- FCF yield-45.3% · higher than 3% of 33
Peer comparison · Medical Care Facilities
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| American Shared Hospital Services🇺🇸 | $10 M | — | -5.8% | -0.9% |
| HCA Healthcare, Inc.🇺🇸 | $96.8 B | 14.3× | 8.6% | +7.1% |
| Fresenius SE & Co. KGaA🇩🇪 | $30.7 B | 20.4× | 5.5% | -3.4% |
| Dr. Sulaiman Al Habib Medical Services Group Company🇸🇦 | $22.2 B | 34.6× | 17.5% | +9.6% |
| Tenet Healthcare Corporation🇺🇸 | $21.4 B | 5.6× | 17.2% | +3.1% |
| IHH Healthcare Berhad🇲🇾 | $18.1 B | 34.8× | 8.2% | — |
| JD Health International Inc.🇨🇳 | $15.7 B | 20.2× | 7.3% | — |
| Apollo Hospitals Enterprise Limited🇮🇳 | $13.5 B | 64.2× | 7.8% | — |
| Fresenius Medical Care AG🇩🇪 | $12.4 B | 11.3× | 5.0% | +5.8% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
- American Shared Hospital Services vs Icecure Medical Ltd
- American Shared Hospital Services vs KDA Group Inc.
- American Shared Hospital Services vs International Medical Center Of Biomaterials Processing and Cryostorage Public Joint-Stock Company
- American Shared Hospital Services and three peers side by side
Similar companies by size and industry
Sources and freshness
- Market cap:
- Aug 1, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As of December 31, 2025
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at American Shared Hospital Services? Verify and update this profile — free
Show American Shared Hospital Services's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.